| 2020 | | COMPARISON OF INFLAMMATORY MARKERS AS DIAGNOSTIC TOOL IN PATIENTS WITH ADULT-ONSET STILL'S DISEASE | 김지원, 김현아, 서창희, 정주양 |
| 2020 | | DISEASE ACTIVITY IS IMPORTANT RISK FACTORS FOR MATERNAL AND FETAL OUTCOMES DURING PREGNANCY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS | 김지원, 김현아, 서창희, 정주양 |
| 2020 | | SEASONAL VARIATIONS AND ASSOCIATED FACTORS OF GOUT ATTACKS: A PROSPECTIVE MULTICENTER STUDY IN SOUTH KOREA | 김현아, 서창희, 정주양 |
| 2020 | | A pharmacokinetic evaluation of the rituximab biosimilar CT-P10 in the treatment of rheumatoid arthritis | 서창희 |
| 2020 | | Simplified disease activity changes in real-world practice: a nationwide observational study of seropositive rheumatoid arthritis patients with moderate-to-high disease activity | 서창희 |
| 2020 | | Systemic Manifestations and Complications in Patients with Rheumatoid Arthritis | 김지원, 서창희 |
| 2020 | | Roles of Interactions Between Toll-Like Receptors and Their Endogenous Ligands in the Pathogenesis of Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still's Disease | 김지원, 김현아, 서창희, 정주양 |
| 2020 | | A Novel Small-Molecule Inhibitor of Endosomal TLRs Reduces Inflammation and Alleviates Autoimmune Disease Symptoms in Murine Models | 서창희 |
| 2020 | | Trabecular Bone Score Is a Useful Parameter for the Prediction of Vertebral Fractures in Patients With Polymyalgia Rheumatica | 김현아, 서창희, 정윤석, 정주양, 최용준 |
| 2020 | | A peptide derived from the core beta-sheet region of TIRAP decoys TLR4 and reduces inflammatory and autoimmune symptoms in murine models | 서창희 |
| 2020 | | A 5-year Retrospective Analysis of Drug Survival, Safety, and Effectiveness of the Infliximab Biosimilar CT-P13 in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis | 서창희 |
| 2020 | | Efficacy and Safety of Rituximab in Korean Patients with Refractory Inflammatory Myopathies | 서창희 |
| 2020 | | Seasonal Variations and Associated Factors of Gout Attacks: a Prospective Multicenter Study in Korea | 김현아, 서창희, 정주양 |
| 2020 | | Impact of immunogenicity on efficacy and tolerability of tumour necrosis factor inhibitors: pooled analysis of biosimilar studies in rheumatoid arthritis | 서창희 |
| 2020 | | The alphaC helix of TIRAP holds therapeutic potential in TLR-mediated autoimmune diseases | 김순선, 서창희, 정재연 |
| 2019 | | Korean Guideline of Glucocorticoid-induced Osteoporosis; Time to Prevent Fracture! | 서창희 |
| 2019 | | Clinical Impact of the Fracture Risk Assessment Tool on the Treatment Decision for Osteoporosis in Patients with Knee Osteoarthritis: A Multicenter Comparative Study of the Fracture Risk Assessment Tool and World Health Organization Criteria | 김현아, 서창희, 정주양 |
| 2019 | | Associated clinical factors for serious infections in patients with systemic lupus erythematosus | 김현아, 서창희, 윤덕용, 정주양, 최영 |
| 2019 | | Polymorphisms of MFGE8 are associated with susceptibility and clinical manifestations through gene expression modulation in Koreans with systemic lupus erythematosus | 김현아, 서창희, 정주양 |
| 2019 | | Efficacy and safety of switching from rituximab to biosimilar CT-P10 in rheumatoid arthritis: 72-week data from a randomized Phase 3 trial | 서창희 |
| 2019 | | Differences in Expression of Human Leukocyte Antigen Class II Subtypes and T Cell Subsets in Behcet's Disease with Arthritis | 김현아, 서창희, 손성향, 정주양 |
| 2019 | | The levels of CXCL12 and its receptor, CXCR4, as a biomarker of disease activity and cutaneous manifestation in adult-onset Still's disease | 권지은, 김현아, 서창희, 임현이, 정주양, 한재호 |
| 2019 | | Efficacy and safety of mycophenolate mofetil and tacrolimus combination therapy in patients with lupus nephritis: a nationwide multicentre study | 서창희 |
| 2019 | | Neutrophil Extracellular Traps May Contribute to the Pathogenesis in Adult-onset Still Disease | 권지은, 김현아, 서창희, 정주양, 최용준, 한재호 |
| 2019 | | Plasma Free Protein S Is Correlated with Disease Activity, but not with Subclinical Atherosclerosis among Patients with Systemic Lupus Erythematosus: A Cross-Sectional Study | 김현아, 서창희, 정주양 |
| 2019 | | NEUTROPHIL-TO-LYMPHOCYTE RATIO AND PLATELET-TO-LYMPHOCYTE RATIO ARE ASSOCIATED WITH DISEASE ACTIVITY IN POLYMYALGIA RHEUMATICA | 김지원, 김현아, 서창희, 정주양 |
| 2019 | | PREVALENCE OF OSTEOPOROSIS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: A MULTICENTER COMPARATIVE STUDY OF THE FRAX AND WHO CRITERIA | 김지원, 김현아, 서창희, 정주양 |
| 2019 | | CHARACTERIZATION OF SALIVARY PROTEINS IDENTIFIED AS POTENTIAL BIOMARKERS FOR SYSTEMIC LUPUS ERYTHEMATOSUS THROUGH PROTEOMIC ANALYSIS | 김지원, 김현아, 서창희, 정주양 |
| 2019 | | A RETROSPECTIVE ANALYSIS OF LONG TERM SAFETY UP TO FIVE YEARS OF INFLIXIMAB BIOSIMILAR CT-P13 IN PATIENTS WITH RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS | 서창희 |
| 2019 | | The role of damage-associated molecular pattern for pathogenesis and biomarkers in adult-onset Still's disease | 김현아, 서창희, 정주양 |
| 2019 | | Rituximab biosimilar CT-P10 for the treatment of rheumatoid arthritis | 김지원, 김현아, 서창희, 정주양 |
| 2019 | | Mindfulness-based cognitive therapy in Korean patients with systemic lupus erythematosus: A pilot study | 김현아, 서창희, 정주양, 조선미 |
| 2019 | | Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio are associated with disease activity in polymyalgia rheumatica | 김현아, 서창희, 정주양 |
| 2019 | | Long-term efficacy, safety and immunogenicity in patients with rheumatoid arthritis continuing on an etanercept biosimilar (LBEC0101) or switching from reference etanercept to LBEC0101: an open-label extension of a phase III multicentre, randomised, double-blind, parallel-group study | 서창희 |
| 2019 | | Body mass index and glucocorticoid dose contribute to subclinical atherosclerosis in Korean patients with systemic lupus erythematosus: A prospective 4 year follow-up study | 김현아, 서창희, 정주양 |
| 2019 | | Amino acid signatures of HLA Class-I and II molecules are strongly associated with SLE susceptibility and autoantibody production in Eastern Asians | 서창희 |
| 2019 | | The Liver X Receptor Is Upregulated in Monocyte-Derived Macrophages and Modulates Inflammatory Cytokines Based on LXRalpha Polymorphism | 김현아, 서창희, 정주양 |
| 2019 | | Long-Term Efficacy and Safety of Biosimilar CT-P10 Versus Innovator Rituximab in Rheumatoid Arthritis: 48-Week Results from a Randomized Phase III Trial | 서창희 |
| 2019 | | Evaluation of factors affecting the levels of physical activity in patients with rheumatoid arthritis: a cross-sectional study | 부선주, 서창희, 정주양 |
| 2019 | | Clinical characteristics and role of whole-body bone scan in multifocal osteonecrosis | 김현아, 박성훈, 서창희, 안영실, 정주양 |
| 2018 | | Transaminase Changes in Korean Rheumatoid Arthritis Patients with Chronic Hepatitis C after Biologic Therapy | 서창희 |
| 2018 | | Productivity Loss of Rheumatoid Arthritis Patients according to the Their Stages of the Disease Activity Score | 서창희 |
| 2018 | | Pulmonary Hypertension in Connective Tissue Disease is Associated with the New York Heart Association Functional Class and Forced Vital Capacity, But Not with Interstitial Lung Disease | 김현아, 서창희, 정주양 |
| 2018 | | Patient with Systemic Lupus Erythematosus Combined with Erosive Arthritis was Treated Successfully with Tocilizumab: A Case Report | 김현아, 박성훈, 서창희, 정주양 |
| 2018 | | AB0029: Characteristic patterns of hla presentation and t cell differentiation in adult-onset still’s disease | 김현아, 서창희, 손성향, 정주양 |
| 2018 | | Polyamine patterns in plasma of patients with systemic lupus erythematosus and fever | 김현아, 서창희, 이광, 정주양 |
| 2018 | | Cell surface polysaccharides of Bifidobacterium bifidum induce the generation of Foxp3(+) regulatory T cells | 서창희, 정주양 |
| 2018 | | Outcome and predictors of renal survival in patients with lupus nephritis: Comparison between cyclophosphamide and mycophenolate mofetil | 김현아, 서창희 |
| 2018 | | Factors associated with quality of life and functional disability among rheumatoid arthritis patients treated with disease-modifying anti-rheumatic drugs for at least 6 months | 서창희 |
| 2018 | | Switching to biosimilars in the treatment of rheumatic diseases | 서창희 |
